Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-22 Sale | 2023-02-24 6:26 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 23,333 | $37.3 | $870,239 | 65,687 (Indirect Direct) | View |
| 2022-07-25 Sale | 2022-07-27 6:17 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 23,334 | $43.18 | $1,007,446 | 19,020 (Indirect Direct) | View |
| 2022-06-24 Sale | 2022-06-24 5:19 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 23,333 | $43.19 | $1,007,694 | 42,354 (Indirect Direct) | View |
| 2022-05-16 Sale | 2022-05-16 7:14 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 23,333 | $39.85 | $929,836 | 65,687 (Indirect Direct) | View |
| 2021-06-04 Sale | 2021-06-08 8:15 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head of R&I | 33,134 | $46.08 | $1,526,721 | 19,020 (Indirect Direct) | View |
| 2021-06-02 Sale | 2021-06-04 6:52 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. | 14,566 | $41.52 | $604,850 | 52,154 (Indirect Direct) | View |
| 2021-05-20 Sale | 2021-05-24 8:10 pm | Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. | 2,000 | $41.08 | $82,159 | 66,720 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-17 Conversion | 2023-02-17 4:57 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 77,000 | $0 | 217,614 (Direct) | View |
| 2022-05-11 Conversion | 2022-05-11 5:20 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments | 77,000 | $0 | 294,614 (Direct) | View |
| 2021-05-07 Conversion | 2021-05-11 9:08 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. | 54,670 | $0 | 211,314 (Direct) | View |
Ownership | 2020-12-31 8:43 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. | 0 | $0 | 1,638,060 (Indirect) | View |